Burning Rock Biotech (燃石医学)
Irvine, California, United States
Burning Rock Biotech Limited (NASDAQ: BNR) focuses on the application of next generation sequencing (NGS) technology in precision oncology. The company provides: i) NGS-based therapy selection testing for late-stage cancer patients, with the leading market share in China and over 300,000 tissue and liquid-based tests completed cumulatively, and ii) cancer early detection, which has moved beyond proof-of-concept R&D into the clinical validation stage.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2014
- Website
- www.brbiotech.com/en/
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of Burning Rock Biotech (燃石医学)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now